Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects By: CNBC.com News December 01, 2023 at 06:49 AM EST Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in mid-2024. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects By: CNBC.com News December 01, 2023 at 06:49 AM EST Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in mid-2024. Read More >>